Trial Profile
Topical Ingenol Mebutate Versus 5% 5-fluorouracil Versus 5% Imiquimod Versus Photodynamic Therapy in Treatment of Actinic Keratosis: a Multi-centre Randomized Efficacy and Cost-effectiveness Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2020
Price :
$35
*
At a glance
- Drugs Fluorouracil (Primary) ; Imiquimod (Primary) ; Ingenol mebutate (Primary) ; Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Acronyms Akti
- 12 Jan 2020 Results assessing a trial-based cost-effectiveness analysis of topical 5-fluorouracil vs imiquimod vs ingenol mebutate vs methylaminolevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area published in the British Journal of Dermatology
- 16 Sep 2019 Results published in the British Journal of Dermatology.
- 28 Sep 2018 Status changed from active, no longer recruiting to completed.